Foresite Capital Management V as of Dec. 31, 2020
Portfolio Holdings for Foresite Capital Management V
Foresite Capital Management V holds 12 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kinnate Biopharma (KNTE) | 25.8 | $35M | 875k | 39.78 | |
| Alx Oncology Hldgs (ALXO) | 20.4 | $28M | 320k | 86.20 | |
| Relay Therapeutics (RLAY) | 12.3 | $17M | 400k | 41.56 | |
| Nurix Therapeutics (NRIX) | 11.0 | $15M | 452k | 32.88 | |
| Oaktree Acquisition Corp. Shs Cl A | 9.4 | $13M | 871k | 14.60 | |
| Population Health Investment Unit | 7.4 | $10M | 960k | 10.45 | |
| Therapeutics Acquisition Corp Com Cl A | 3.6 | $4.9M | 350k | 13.92 | |
| Bctg Acquisition Corp | 3.4 | $4.6M | 400k | 11.44 | |
| Lifesci Acquisition Ii Corp | 3.2 | $4.3M | 400k | 10.67 | |
| Helix Acquisition Corp. Com Cl A | 2.1 | $2.8M | 250k | 11.37 | |
| Consonance-HFW Acquisition Corp. Unit | 0.8 | $1.0M | 100k | 10.47 | |
| Abcellera Biologics (ABCL) | 0.6 | $805k | 20k | 40.25 |
